DelfaGLP-1 Atlas

Lead sponsor

Seoul National University Bundang Hospital

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

0

Active

215

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 4
1
Not applicable
1

Trials by status

Completed
1
Unknown
1

Trials led

Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DBMI ≥23Ph 4Unknown135
The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular RiskHbA1c ≤10%not applicableCompleted80